Browse > Article

No Role of Protected Region B of Human Cytochrome P4501A2 Gene (CYP1A2) As an AP-1 Response Element  

Chung, In-Jae (College of Pharmacy, Duksung Womens University)
Jung, Ki-Hwa (College of Pharmacy, Duksung Womens University)
Publication Information
Archives of Pharmacal Research / v.25, no.3, 2002 , pp. 375-380 More about this Journal
Abstract
Cytochrome P4501A2 (CYP1A2) is a member of the cytochrome P450 family of isozymes involved in the phase I drug metabolism of vertebrates. CYP1A2 is responsible for the activation of a number of aromatic amines to mutagenic and carcinogenic forms. Thus, the level of CYP1A2, which varies among different populations, may determine an individual's susceptibility to these chemicals. We have previously reported on the importance of a cis element named PRB (protected region B) in the regulation of human Cytochrome P4501A2 (CYP1A2) gene, which appeared to act as a positive regulatory element. Closer examination of the PRB sequence (-2218 to -2187 bp) revealed a putative AP-1 binding site, TGACTAA, at -2212 bp (Chung and Bresnick, 1997). To elucidate the role of AP-1 in CYP1A2 regulation, we transiently overexpressed c-Jun and c-Fos transcription factors in human hepatoma HepG2 cells, and examined their influence on the CYP1A2 promoter activity by reporter gene assays. Cotransfection of the c-Jun and the c-Fos expression vectors increased the induced transactivation by five to six fold from the CYP1A2 promoter constructs. However, deletion of the PRB element did not affect the degree of activation by the c-Jun and the c-Fos. Therefore, it is unlikely that the c-Jun and the c-Fos activate the CYP1A2 promoter through this AP-1 consensus-like sequence in the PRB region.
Keywords
Cytochrome P4501A2; CYP1A2; AP-1; Gene expression; c-Jun; c-Fos; PRB; HepG2; Hapatoma;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Battula, N., Sagara, J., and Gelboin, H. V., Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochrome P-450 in mammalian cells. Proc. Natl. Acad. Sci. USA, 84,4073-4077 (1987)   DOI   ScienceOn
2 Chung, I., and Bresnick, E., Regulation of the constitutive expression of the human CYP1A2 gene: cis-elements and their interactions with proteins. Mol. Pharmacol., . 47, 677-685(1995)   PUBMED
3 Groves, W. E., Davis, F. L., and Shells, B. H., Spectrophotomeric determination of microgram quantities of protein without nucleic acid interference. Anal. Biochem., 22, 195-210 (1968)   DOI   ScienceOn
4 loannides, C., and Parke, D. V., Induction of cytochrome P4501 as indicator of potential chemical carcinogenesis. Drug Metab. Rev., 25, 485-501 (1993)   DOI   ScienceOn
5 Jones, N. C., Rigby, P.W. J., and Ziff, E. B., Transacting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes and Development. Vol. 2. New York: Cold Spring Harbor Laboratory. (1988)
6 Nakajima, M., Yokoi, T., Mizutani, M., Shin, S., Kadlubar, F. F, and Kamataki, T., Phenotyping of CYP1A2 in Japaneses population by analysis of caffeine urinary metabolite: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol, Biomarkers Prev., 3, 413-421(1994)
7 Quattrochi, L. C., Shih, H., and Pickwell, G. V., Induction of the Human CYP1A2 enhancer by phorbol ester. Arch. Biochem. Biophys., 350,41-48 (1998)   DOI   ScienceOn
8 Sesardic, D., Pasanen, M., Pelkonen, O., and Boobis, A. R., Differential expression and regulation of members of the cytochrome P4501A gene subfamily in human tissues. Carcinogenesis., 11, 1183-1188 (1990)   DOI   ScienceOn
9 Adamson, R. H., Thorgeirsson, U. P, Snyderwine, E. G., Thorgeirsson, S. S., Reeves, J., Dalgard, D. W., Takayama, S., and Sugimura, T., Carcinogenicity of 2-amino-3-methylimidazo (4,5-f)quinoline in nonhuman primates: induction of tumors in three macaques. Gann,. 81,10-14(1990)   DOI
10 Wrighton, S. A., Campanile, C., Thomas, P. E., Paines, S. L., Watkins, P. B., Parker, G., Mendex-Picon, G., Haniu, M., Shively, J. E., Levin, W., and Guzelian, P. S., Mol. Pharmacol., 29, 405-410 (1986)   PUBMED
11 Hai, T., and Curran, T., Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA, 88, 3720-3724 (1991)   DOI   ScienceOn
12 Aoyama, T., Gonzalez, F. J., and Gelboin, H.V, Mutagen activation by cDNA-expressed P(1)450, P(3)450, and P450a. Mol. Carcinogesis., 1,253-259 (1989)   DOI   ScienceOn
13 Angel, P., Hattori, K., Smeal, T., and Karin, M., The jun proto-oncogene is positively autoregulated by its product, Jun/AP1. Cell, 55, 875-885(1988)   DOI   ScienceOn
14 Chung, I. and Bresnick, E., Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch. Biochem. Biophys., 338,220-226 (1997)   DOI   ScienceOn
15 Lamph , W. W., Wamsley, P., Corpi, P-S., and Verma, I. M., Induction of proto-oncogene Jun/AP-1 by serum and TPA. Nature, 334, 629-631 (1988)   DOI   ScienceOn
16 Sambrook, J., Fritsch, E. F., and Maniatis, T., Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. (1989)
17 Suzuki, T., Okuno, H., Yoshida, T., Endo, T., Nishina, H,., and Iba., H., Difference in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res., 19,5537-5542(1991)   DOI   ScienceOn
18 Chung, I., and Bresnick, E., 3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcription-polymerase chain reaction. Arch. Biochem. Biophys., 314, 75-81 (1994)   DOI   ScienceOn
19 Brasier, A. R., Tate, J. E., and Habener, J. F., Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques, 7,1116-1122 (1989)   PUBMED
20 Schweikl, H., Taylor, J. A., Kitareewan, T. S., Linko, P., Nagomey, D., and Goldstein, J. A., Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics, 3, 239-249 (1993)   DOI   ScienceOn
21 Sonnenberg, J. L., Rauscher, F J., III, Morgan, J. I., and Curran, T., Regulation of proenkephalin by Fos and Jun. Science, 246, 1622-1625 (1989)   DOI   PUBMED
22 Lee, W., Mitchell, P., and Tjian, R., Purified transcriptional factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49,741-752 (1987)   DOI   ScienceOn
23 Kalow, W., and Tang, B. K., Use of caffeine metabolite ratio to explore CYP1A2 and xanthine oxidase activities. Clin. Pharmacol. Ther., 50, 508-519 (1991)   DOI   ScienceOn
24 Sesardic, D., Boobis, A. R., Edwards, R. J., and Davies, D. S., A form of cytochrome P450 in man, orthlogous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol., 26,363-372 (1988)   DOI   PUBMED   ScienceOn
25 Angel, P., and Karin, M., The role of jun, fos, and the AP-1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta, 1072, 129-157 (1991)
26 Abate, C., Baker, S. J., Lees-Miller, S. P., Anderson, C. W., Marshak, D. R., and Curran, T., Dimerization and DNA binding alter phosphorylation of Fos and Jun. Proc. Natl. Acad. Sci. USA., 90, 6766-6770 (1993)   DOI   ScienceOn
27 Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D., Waterman, M. R., Gotoh, O., Coon, M. J., Eastabrook, .R W, Gunsalus, I. C., and Nebert, D. W, P-450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6,1-42 (1996)   DOI   ScienceOn